Financial statements Invex Remedies
Balance sheet data of INVEX REMEDIES
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 3 726 434,31 | 5 041 549,34 | 7 115 607,67 | 6 621 012,10 | 8 212 015,52 | 9 857 396,03 |
A. Fixed assets | 857 499,73 | 461 167,19 | 170 428,56 | 173 453,77 | 635 576,43 | 1 757 727,04 |
B. Current assets | 2 868 934,58 | 4 580 382,15 | 6 945 179,11 | 6 447 558,33 | 7 576 439,09 | 8 099 668,99 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 3 726 434,31 | 5 041 549,34 | 7 115 607,67 | 6 621 012,10 | 8 212 015,52 | 9 857 396,03 |
A. Equity | 2 244 793,00 | 3 747 107,83 | 5 832 478,06 | 5 684 267,69 | 7 525 608,73 | 9 195 545,47 |
B. Liabilities and provisions for liabilities | 1 481 641,31 | 1 294 441,51 | 1 283 129,61 | 936 744,41 | 686 406,79 | 661 850,56 |
I. Long-term liabilities | 407 632,55 | 313 388,22 | 211 762,41 | 108 982,65 | 0,00 | 0,00 |
II. Short-term liabilities | 1 074 008,76 | 981 053,29 | 1 071 367,20 | 827 761,76 | 686 406,79 | 661 850,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.